Advarra Unveils Oncology Research Pulse

by palligoelme@gmail.com | Mar 12, 2025 | Clinical Trials

​  /PRNewswire/ — Advarra, the market leader in regulatory review solutions and clinical research technology, today announced the launch of Oncology Research…  /PRNewswire/ — Advarra, the market leader in regulatory review solutions and clinical...

QurAlis Announces Topline Data From its Phase 1 Clinical Trial of QRL-101 Evaluating Biomarkers of ALS and Epilepsy in Healthy Volunteers

by palligoelme@gmail.com | Mar 12, 2025 | Clinical Trials

​  /PRNewswire/ — QurAlis Corporation (“QurAlis”), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that…  /PRNewswire/ — QurAlis Corporation (“QurAlis”), a...

Gilead Sciences’ annual HIV prevention injection shows promise in clinical trial, Lancet study reveals

by palligoelme@gmail.com | Mar 12, 2025 | Clinical Trials

​  The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 weeks, according to the phase 1 randomised controlled trial.  The drug, which works by blocking HIV from entering and multiplying in human...

RedHill Biopharma Advances its Groundbreaking Late-Stage Crohn’s Disease Program Building on Statistically Significant Positive RHB-104 Phase 3 Results

by palligoelme@gmail.com | Mar 12, 2025 | Clinical Trials

​  The planned innovative Phase 2 study of RHB-2041 will be the first ever clinical study in Crohn’s Disease (CD) patients who are all MAP-positive, and will…  The planned innovative Phase 2 study of RHB-2041 will be the first ever clinical study in...